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Abstract 
 
Vascularization is a major challenge in tissue engineering. Different strategies exist, 
and cell-based approaches have emerged as a promising therapy to achieve successful 
vascularization. Co-culture systems of endothelial cells (ECs) and other supporting cells 
may have an important role in what refers to cellular crosstalk, namely through the 
production of growth factors and extracellular matrix (ECM) synthesis. Since activation 
and migration of fibroblasts is required for several physiological events that rely on 
angiogenesis, the hypothesis underlying the research reported in the present work is that 
human outgrowth endothelial cells (OECs) and mature ECs respond differently when co-
cultured with different types of human fibroblasts, in what concerns the formation of 
capillary-like structures. To investigate this, OECs were isolated from human umbilical 
cord blood samples and characterized by immunofluorescence, western blot and 
imaging flow cytometry. Also, two types of human dermal fibroblasts were used (neonatal 
human foreskin fibroblasts – HFF-1 – or juvenile human dermal fibroblasts – HDF), being 
characterized in terms of the expression of podoplanin (PDPN) and transglutaminase-2 
(TG2), markers of dermal fibroblasts, as well as alpha smooth muscle actin (α-SMA), a 
marker of fibroblast activation. Co-culture systems were established using either human 
umbilical vein ECs (HUVECs) or OECs with HFF-1 or HDF. Two 3D systems were 
compared in the present work – one in 3D without the addition of an external ECM (co-
culture) and another in 3D with the addition of an external ECM (matrigel) at the 
beginning of the assay. Several culture time points were evaluated: 7, 14 and 21 days 
for the co-culture system; 24h, 48h and 7 days for the matrigel assay. The formation of 
capillary-like structures was assessed by immunocytochemistry against CD31 and vWF 
proteins. Parameters such as the number of tubular structures and branching points, 
length and thickness were evaluated. The presence of ECM components, such as 
collagen types I and IV, laminin and fibronectin, was assessed in all cell types and in co-
cultures of HUVEC/HDF by immunofluorescence and western blot. 
OECs expressed several endothelial markers, including CD31, VE-cadherin and 
vWF, as well as VEGFR2 and CD34. HFF-1 exhibited a higher expression of TG2 than 
that observed for HDF, while HDF expressed higher amounts of PDPN and α-SMA. 
Fibroblasts influenced the formation of capillary-like structures by endothelial cells. 
Indeed, the formation of capillary-like structures was only observed in co-cultures with 
HDF and not with HFF-1 fibroblasts. In addition, in the co-culture system, HUVECs 
formed a highly branched capillary-like network to a great extent than that observed for 
OECs. In the matrigel assay, HUVECs and OECs behaved similarly when co-cultured 
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with HDF. In terms of ECM, HUVECs were found to secrete collagen type IV, fibronectin 
and laminin to the extracellular media, whereas in OECs these proteins were only 
detected intracellularly. HDF were able to secrete all the investigated ECM components, 
primarily collagen I, which is lacking in HUVECs, OECs and HFF-1. In co-cultures of 
HUVEC/HDF, it was observed that all investigated ECM components were present, with 
collagen types I and IV being mainly expressed where capillary-like structures were 
present. 
These findings suggest that HDF is a preferential cell source for enhancing 
vascularization, both in HUVECs and OECs. Given the already described advantages of 
OECs, these findings open a new field of research regarding the use of specific fibroblast 
populations co-cultured with OECs, as efficient partners for vascular development with 
tissue regeneration purposes. 
 
 
 
Keywords: Endothelial cells, Co-culture models, Fibroblasts, Tissue Regeneration, 
Vascularization  
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Resumo 
 
A vascularização é um dos maiores desafios em engenharia de tecidos. Existem 
diferentes estratégias e abordagens baseadas no uso de células emergiram como 
terapia promissora para se alcançar, com sucesso, vascularização. Os sistemas de co-
culturas de células endoteliais (CEs) com outras células de suporte podem ter um papel 
importante no que se refere à comunicação celular, nomeadamente através da produção 
de fatores de crescimento e síntese de matriz extracelular (MEC). Dado que a ativação 
e migração de fibroblastos são requisitos de diversos eventos fisiológicos que 
dependem de processos angiogénicos, a hipótese subjacente ao presente trabalho é a 
possibilidade de células endoteliais progenitoras tardias (OECs) e ECs maduras 
responderem de forma distinta quando co-cultivadas com diferentes tipos de 
fibroblastos, em termos de formação de estruturas semelhantes a capilares. A fim de 
investigar esta hipótese, OECs foram isoladas a partir de amostras de sangue do cordão 
umbilical humano e caracterizadas por imunofluorescência, western blot e citometria de 
fluxo. Dois tipos de fibroblastos humanos da derme foram igualmente usados 
(fibroblastos neonatais humanos – HFF-1 – ou fibroblastos juvenis humanos – HDF), 
sendo caracterizados em termos da expressão de marcadores fibroblásticos da derme, 
incluindo podoplanina (PDPN) e transglutaminase-2 (TG2), assim como α-actina de 
músculo liso (α-SMA), um marcador de ativação de fibroblastos. Sistemas de co-culturas 
foram estabelecidos, usando tanto CEs de veia umbilical humana (HUVECs) ou OECs 
com HFF-1 ou HDF. Dois sistemas 3D foram comparados no presente trabalho – um 
sem adição de uma matriz externa (co-cultura) e outro em que se adicionou uma matriz 
(matrigel) no início do ensaio. Foram avaliados diversos tempos de cultura. 7, 14 e 21 
dias, no sistema de co-cultura; 24, 48h e 7 dias, no caso do ensaio em matrigel. A 
formação de capilares foi determinada através de imunocitoquímica contra as proteínas 
CD31 e vWF, tendo sido avaliados parâmetros como o número de estruturas tubulares 
e pontos de ramificação, comprimento e diâmetro. A presença de componentes da MEC, 
incluindo colagénios tipos I e IV, laminina e fibronectina, foi estudada em todos os tipos 
de células e nas co-culturas de HUVEC/HDF por imunofluorescência e western blot. 
As OECs expressaram vários marcadores endoteliais, incluindo CD31, VE-caderina 
e vWF, bem como VEGFR2 e CD34. Os HFF-1 exibiram uma maior expressão de TG2, 
enquanto os HDF expressaram PDPN e α-SMA em maiores quantidades. Os 
fibroblastos influenciaram a formação de estruturas-tipo capilares pelas células 
endoteliais. De facto, a formação de estruturas-tipo capilares foi apenas observada 
apenas nas co-culturas com HDF e não com HFF-1. Além disso, no sistema de co-
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cultura, as HUVECs formaram uma rede-tipo capilar altamente ramificada, numa maior 
extensão do que aquela observada no caso das OECs. No ensaio de matrigel, HUVECs 
e OECs tiveram um comportamento semelhante quando co-cultivadas com HDF. No 
que se refere à MEC, observou-se que as HUVECs secretaram colagénio tipo IV, 
fibronectina e laminina para o meio extracelular, enquanto as mesmas proteínas nas 
OECs foram detetadas apenas intracelularmente. Os HDF também secretaram todos os 
componentes da MEC, principalmente colagénio tipo I, que não foi encontrado nas 
HUVECs, OECs e HFF-1. No sistema de co-cultura de HUVEC/HDF, observou-se que 
estavam presentes todos os componentes da MEC investigados, sendo os colagénios 
tipo I e IV maioritariamente expressos onde estruturas-tipo capilares estavam presentes. 
Estes resultados sugerem os HDF como um fonte preferencial de células para 
melhorar a vascularização, tanto com HUVECs como com OECs. Tendo em 
consideração as vantagens já descritas para as OECs, os presentes resultados criam 
uma nova área de investigação, no que respeita ao uso de populações específicas de 
fibroblastos em co-cultura com OECs, enquanto parceiros eficazes para o 
desenvolvimento vascular com fins de regeneração de tecidos. 
 
 
 
 
Palavras-chave: Células endoteliais, Modelos de co-culturas, Fibroblastos, 
Regeneração de Tecidos, Vascularização  
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CHAPTER I  
 
 
 
INTRODUCTION 
 
 
 
 
 
1.1. The relevance of vascularization in Tissue Engineering 
The regeneration of a lost or damaged tissue function in the adult generally involves 
a recapitulation of developmental processes, consequently implying the replication of 
biological concepts and instructions expressed during the embryonic development (1). 
This is the main reason why regeneration of large defects in a human adult tissue does 
not occur naturally. The majority of reconstruction and cosmetic surgeries use 
autologous donor sites as a source of soft tissue, which creates a secondary wound and 
increases surgery and recovery times, as well as a higher risk of infection and potential 
loss of function, resulting in a great demand for engineered/ artificial soft tissues for 
clinical applications (2). 
Each tissue is constituted by several cell types, resulting in a complex structure, 
highly organized and integrated into the body, namely through the vascular and the 
nervous systems. Tissue engineering has been evolving as an interdisciplinary science 
which intends to restore, maintain or improve tissue function (3). In general terms, tissue 
engineering aims for the creation of adequate tissue or even organ equivalents, which 
is, therefore, a highly challenging task (4). Nowadays, only in vitro tissue engineered 
products for skin and cartilage are successfully used in clinics (5), since their demands 
in terms of blood supply are reduced, owing to the fact that these tissues are supplied 
through diffusion from distant blood vessels. However, the maximum diffusion distance 
of nutrients and oxygen out of blood vessels is 200 µm (6) and, due to mass transfer 
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limitations, organs with a more complex tridimensional structure actually need an 
integrated vascular network to support cell survival. 
Overall, the inability to engineer blood vessels in vitro for subsequent transplantation 
has been referred as the main reason associated to the limited clinical success of tissue 
engineering strategies (5, 7, 8). When a tissue engineered construct, including 
transplanted cells, faces insufficient blood supply, associate problems arise due to the 
lack of nutrients and oxygen transportation, as well as elimination of metabolites, 
resulting in functional limitations of the bioengineered tissue or even to the failure of the 
implanted construct. Hence, several strategies have been investigated concerning 
vascularization for tissue engineering applications (Fig. 1.1), like growth factor delivery, 
cell transplantation and the use of materials for immobilization strategies (scaffold-based 
approaches), which have been extensively reviewed (5, 7, 9). In fact, there have been 
different efforts to develop new therapies so that a faster and successful vascularization 
is achieved. 
 
 
Figure 1.1. Summary of strategies used to promote vascularization for tissue engineering 
applications. Growth factor delivery and cell transplantation are traditional strategies that present several 
associated problems and have been improved through their combination and the use of scaffold materials.  
 
1.2. The vascular network 
The vascular network is responsible not only for the transport of gases, nutrients and 
metabolites, but also for the circulation of signalling molecules, hormones and antibodies 
between tissues and organs. Also, blood vessels work as a transport system for factors 
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that are produced by endothelial cells (ECs), particularly angiogenic factors, like vascular 
endothelial growth factor (VEGF). 
The complex structure of the vascular network is achieved by the maturation of the 
immature blood vessels previously formed by angiogenesis or vasculogenesis (10). 
Vasculogenesis refers to the in situ formation of vessels orchestrated directly by 
endothelial precursor cells or angioblasts, whereas angiogenesis is defined as the 
process of new blood vessels formation through the sprouting of preexisting vasculature. 
Vasculogenesis is of major importance during embryonic development, but plays also a 
role in adulthood both in physiological, as well as in pathological conditions. On the other 
hand, angiogenesis plays a crucial role throughout postnatal life, being related to wound 
healing and the menstrual cycle (11, 12), inflammatory processes and also some 
pathological conditions, as rheumatoid arthritis, diabetic retinopathy, macular 
degeneration and tumor growth (13, 14), as well as accompanying growth repair, tissue 
remodeling and regeneration (6, 10, 15, 16). 
The recruitment of new blood vessels through the activation of these two main 
processes of vascularization is still considered to be a great challenge in regenerative 
approaches. Different blood vessels exist, which express characteristic molecular 
markers. Endothelial precursors that form arteries express ephrin B2 (Efnb2), whereas 
its receptor, the B4 ephrin receptor (Ephb4), is preferentially expressed in veins (17). 
However, all blood vessels are formed by one thin inner layer of ECs, the endothelium, 
which is then covered by supporting cells, such as pericytes or smooth muscle cells and 
fibroblasts, which contribute for vessel stabilization and maturation. This vascular 
endothelium provides a selective barrier, separating the blood stream from the 
underlying tissues, with vascular wall cells being thus embedded in an extracellular 
matrix (ECM, Fig. 1.2). 
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Figure 1.2. Schematic representation of the biological processes involved in vascularization, 
including cell-cell/ cell-matrix interactions. The vascular endothelium is formed by one layer of 
endothelial cells (EC). Their expression of adhesion molecules, like VE-cadherin and angiopoietin (Ang)-1, 
allows for intercellular interactions, which are important for vessel stabilization. Vascular maintenance is 
achieved through specific signaling (release of growth factors and signaling molecules) and direct physical 
contact between endothelial cells and mural cells, such as smooth muscle cells (SMC) and perycites, or 
fibroblasts. The extracellular matrix (ECM) will act as a bridge between blood vessels and the surrounding 
tissue. Moreover, different populations of endothelial progenitor cells exist in circulation – early endothelial 
progenitor cells (EPC) and outgrowth endothelial cells (OEC). These cells have distinct roles in 
vascularization: EPCs contribute for vascularization/angiogenesis in a paracrine manner through the release 
of growth factors, while OECs are able to contribute for the repair and formation of blood vessels by 
differentiating into mature ECs.  
 
1.2.1. Endothelial cells 
Endothelial cells (ECs) play a pivotal role in vascularization, forming the vascular 
endothelium. These cells characteristically express von Willebrand factor (vWF), platelet 
endothelial cell adhesion molecule-1 (PECAM-1 or CD31), and vascular endothelial 
(VE)-cadherin (18-20). However, molecular differences exist between endothelial cell 
populations due to the heterogeneity along this cell lineage, resulting in high variability 
when their functional behavior is assessed through angiogenesis assays (21). Some 
authors consider that mature endothelial cells (ECs) present a limited regenerative 
potential (22). The discovery of putative endothelial progenitor cells (EPCs) in 1997 (23) 
contributed to enlarge the knowledge of endothelial cell populations and to change the 
prevailing dogma until then, which stated that throughout postnatal life new blood vessels 
could only be generated by fully differentiated ECs. In fact, blood vessels are believed to 
be newly formed by endothelial precursors (15).  
Although embryonic and adult stem cells exhibit a higher proliferative capacity (24), 
the use of EPCs has emerged as an alternative to them (25). EPCs exist in circulation 
  5 
and have been described as being capable of incorporating into vessels after 
mobilization from bone marrow, in order to participate in neovascularization at sites of 
ischemia (23). These cells overcome some ethical considerations along with a deficient 
knowledge considering the control of embryonic stem cells differentiation (26). Two 
different types of EPCs are believed to exist, early EPCs and late EPCs, here called 
outgrowth endothelial cells (OECs) (20, 22, 27, 28), being commonly isolated from 
peripheral or umbilical cord blood. Other sources of endothelial progenitors include the 
adipose tissue (29, 30) and the amniotic fluid (31). Moreover, several works refer the 
bone marrow as a reservoir of EPCs (32-34), while others reported that these cells 
cannot be isolated from the bone marrow neither from cells mobilized from this organ 
(35). This finding defies the concept of bone marrow-derived circulating precursors of 
endothelial cells, originating further speculation about the eventual existence of a 
vascular source outside the bone marrow, or of a common precursor for endothelial 
progenitor cells and for hematopoietic stem cells. There is a great need to further explore 
these issues in future works, to improve knowledge on vascular biology, so that it can be 
applied to the development of tissue engineering strategies. 
Despite their origin, these progenitor cells seem to be mobilized into circulation, 
contributing to the neovascularization process (24). However, there is still great 
controversy associated to the term “endothelial progenitor cell”. The main distinguishable 
features of both types of EPCs are briefly described in table 1.1. Early EPCs appear after 
4 to 7 days in culture and have been described as bone marrow-derived cells, sharing 
surface markers expressed by hematopoietic stem cell populations, as CD14, CD45 and 
CD133 (20, 23, 36, 37), differentiating into phagocytic macrophages and possessing 
myeloid progenitor cell activity (38). On the other hand, OECs appear much later, after 
14 to 21 days, exhibiting typical endothelial characteristics and being reported to 
incorporate into resident vasculature (22, 28, 39). Some authors reported that early 
EPCs failed to form interconnected vascular networks de novo, whereas OECs formed 
branching interconnected vascular networks after 72 hours in co-culture, being maximal 
after 14 days (22), which suggests a higher angiogenic potential associated to OECs 
(39). Moreover, early EPCs have been shown to preferentially express genes involved 
in immune responses and inflammation, while OECs expressed genes involved in 
development and angiogenesis, including the angiopoietin receptor Tie2, endothelial 
nitric oxide synthase (eNOS), ephrins and transforming growth factor (TGF)-β (20). A 
more recent study also showed that umbilical blood derived OECs secrete a broad 
spectrum of proinflammatory and angiogenic cytokines, including angiogenin, 
angiopoietin (Ang)-2 and platelet-derived growth factor (PDGF)-BB (40). 
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Table 1.1. Overview on characteristics that distinguish between EPCs and OECs. Adapted from Fuchs et al. 2010 (4) and Yoon et al. 2005 (41). 
 
 EPCs OECs Marker functions 
Morphology  
(4, 27, 41) 
 
Spindle shaped morphology 
 
Cobblestone-like morphology 
 
 
Appearance in culture After 7 days in culture (4, 42)  After 2-3 weeks in culture (4, 27)   
Human phenotypic markers CD31+ (22, 23) 
CD45+ (22, 43)  
CD34+ (23, 41)  
CD14+ (22, 41)  
CD146+ (22) 
CD133+ (44-46)  
Flt-1+ (42) 
eNOS (42) 
vWF+ (38, 42)  
VE-cadherin+ (42, 47)  
KDR+ (22, 42, 47)  
CD36+ (27) 
Tie2+ (23, 48)  
Caveolin-1- (20) 
CD115+ (38)  
CD31+ (18, 22) 
CD45- (22, 43)  
CD34+ (41, 43)  
CD14- (22, 41)  
CD146+ (18, 22)  
CD133- (43) 
Flt-1+ (42) 
eNOS (42) 
vWF+ (18, 38, 42)  
VE-cadherin+ (18, 27, 42)  
KDR+ (22, 41, 42)  
CD36+ (27) 
Tie2+ (48) 
Caveolin-1+ (18, 20, 48)  
CD115- (38) 
Cell contact protein that mediates homotypic EC adhesion. 
Surface transmembrane phosphatase expressed in hematopoietic lineage cells. 
Stem-cell-related marker. 
Monocyte surface marker. 
Adhesion molecule that mediates homotypic EC adhesion.   
Stem-cell-related surface marker. 
VEGF receptor-1. 
Modulates VEGF-induced angiogenesis and vascular permeability in vivo. 
Constitutive glycoprotein of the endothelium. 
Cell contact protein that mediates homotypic EC adhesion. 
VEGF receptor-2. 
Receptor of TSP-1 and mediator of its anti-angiogenic activity 
Cell surface receptor that bind and is activated by the angiopoietins. 
Marker of endothelial differentiation. Upregulated during vessel formation. 
Macrophage-specific antigen. 
Proliferative potential Low (22, 41, 42)  High (22, 41, 42)   
Tube formation No (22, 42, 48) Yes (22, 42, 48)  
Paracrine augmentation of angiogenesis  Yes (22) No (22)  
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1.2.2. Mural cells 
Endothelial cells first associate to form tubules and afterwards mural cells are 
recruited allowing vessel maturation and stability (10). Signals involved in the recruitment 
and coverage of ECs by mural cells include PDGF-B, Ang1, TGF-β and NOTCH 
signaling (16). 
Different mural cells exist depending on their morphology, location and the 
expression of specific markers, being divided into pericytes and smooth muscle cells 
(SMCs) (49) and contacting the microvascular basement membrane in different 
microvascular beds (50). Vascular SMCs are present in larger blood vessels, as arteries 
and veins, forming multiple concentric layers, whereas microvessels are covered by 
pericytes often organized in a discontinuous cell layer around the endothelial cell tube 
(49) and embedded within the vascular basement membrane (50) (Fig. 1.3).  
 
 
Figure 1.3. Schematic representation of blood vessels constitution. (A) Capillaries are the most 
abundant vessels in the human body, consisting of endothelial cells surrounded by basement membrane 
and a sparse layer of pericytes embeeded within the basement membrane. (B) Arterioles and venules are 
the vessels that will originate arteries and veins, respectively, and are covered by smooth muscle cells, 
having an increased coverage of mural cells, when compared to capillaries. Adapted from Jain (10). 
 
These periendothelial cells contribute to stabilize blood vessels through direct 
physical contact (51), ECM deposition (52) and growth factors release, as VEGF and 
Ang-1 (16, 51, 52). 
Different tissues exhibit varying mural cell morphology and different degrees by 
which they cover the endothelium (49). 
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1.2.3. Fibroblasts 
Fibroblasts are mesenchymal cells and can be quite different in terms of cell 
dynamics, depending on their tissue of origin (53). They are the main source of ECM 
components (53, 54), including collagen I, fibronectin and proteoglycans (55). Human 
fibroblasts are abundant in the dermis and can be easily obtained from minimally invasive 
skin biopsies, using standard laboratory protocols (56, 57). Therefore, human dermal 
fibroblasts have been quite used for skin tissue engineering applications and have 
gained an increasing interest as a cell source for other applications, like 
neovascularization. Considering their location within the dermis, human dermal 
fibroblasts are divided into papillary (superficial dermis) and reticular (deep dermis) 
fibroblasts, exhibiting different characteristics in terms of cell morphology, production of 
ECM and growth factors, among others (58, 59). Although there is no specific marker to 
distinguish both fibroblasts, Janson et al. investigated the differences in gene expression 
patterns between these two types of fibroblasts, reporting that reticular fibroblasts 
showed an increased expression of genes involved in cell motility and contraction, 
including calponin 1 and transglutaminase 2, whereas papillary fibroblasts 
characteristically expressed genes involved in the immune response, such as netrin-1 
and podoplanin (59). In what concerns to vascularization, a study reported that papillary 
fibroblasts were able to support the formation of highly branched tubular-like structures 
in vitro, while reticular fibroblasts were not (60). Therefore, human dermal fibroblasts 
might be used in cell therapies aiming for the revascularization of a damaged tissue. 
For instance, the adventitial layer of large blood vessels is mainly composed by 
fibroblasts and associated ECM components (52). Besides, fibroblasts secrete potent 
angiogenic factors, like VEGF and fibroblast basic factor (FGF)-2, as well as matrix 
metalloproteinase (MMP)-2 and MMP-9 (61), which are proangiogenic 
metalloproteinases. Hence, it is possible that fibroblasts act as periendothelial 
progenitors in vivo (52), supporting EC survival and migration, as well as modulating the 
expansion of capillary-like networks, particularly in vitro (62). Moreover, since fibroblasts 
generate a scaffold for other cells through matrix deposition, they may alter the 
mechanical extracellular microenvironment, regulating vascularization processes (63). 
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1.3. The extracellular matrix 
The ECM acts as a bridge between vascular wall cells and the respective surrounding 
tissues. Providing a three-dimensional (3D) support for EC proliferation and survival, 
ECM has a dual role – it acts as an adequate substrate for the organization of ECs into 
microvessels, simultaneously retaining and concentrating growth factors in the cellular 
microenvironment (61). ECM is therefore considered a reservoir of proteins that are 
involved in several physiological events, including wound healing and angiogenesis. The 
presence of proteases or protease inhibitors leads to changes in the bioavailability of 
matrix-sequestered factors (64). 
Capillary morphogenesis is regulated through the immobilization of angiogenic 
cytokines, growth factors and other molecular cues involved in angiogenic activation 
(65), as well as by angiogenesis inhibitors (66). MMPs exist, which release pro-
angiogenic (67) and anti-angiogenic peptides (68), through ECM cleavage (69). In 
particular, the endothelium is separated from the connective tissue by the basement 
membrane, a specialized layer of ECM where collagen IV and laminin, together with 
heparin sulfate proteoglycans, organize into networks, being both essential for basement 
membrane stability (70, 71). Collagen IV has been described as having the capacity to 
modulate the angiogenic response in a rat aorta model, resulting in the elongation of the 
neovessels (72). On the other hand, cleavage of collagen IV may result in the release of 
tumstatin and other angiogenesis inhibitors (66), showing the relevance of the ECM in 
regulating vascularization, among other physiological processes. In the case of laminins, 
they have been shown to be involved in the regulation of blood vessel diameter, rather 
than vascular development, in a model of embryoid bodies (71). 
In addition, it is worth to mention that fibronectin, a component from the ECM of 
developing microvessels, also acts as a scaffold for cell adhesion and migration (73, 74) 
and plays a role in the elongation of these developing microvessels (75). 
Moreover, ECM stiffness has also been proved to be essential for lumen formation 
by ECs (76). 
Given that ECM proteins also possess binding sites for cells to adhere through their 
surface receptors, ECM acts as a key controller of cell behavior, activating several 
intracellular signaling pathways and, in turn, cells degrade and remodel the ECM (65, 
70, 77). Hence, understanding cell-matrix interactions is of major importance to mimic 
the natural ECM when developing functionalized biomaterials that provide biospecific 
cell adhesion and control cellular functions (78), since the ECM corresponds to a natural 
scaffold for tissue development and repair, supporting tissue reconstruction (79). 
 
 10 
1.4. Cellular crosstalk and communication: the case of co-culture systems 
Co-culture systems may have an important role in what refers to cellular crosstalk, 
namely through the production of growth factors and ECM synthesis. The importance of 
a co-culture system relies on the intricate communication pathways that are established 
between different cell types, both through diffusible signaling molecules and by cell-cell 
contacts. In fact, angiogenesis is controlled by the interaction between ECs and other 
cell types (80) and different works have shown that cells expressing smooth muscle cell/ 
pericyte markers, such as α-smooth muscle actin (α-SMA), appeared in close proximity 
to capillary-like structures (26, 52, 81, 82). Hence, this section will focus on the use of 
ECs in co-culture systems to promote vascularization in tissue engineering. 
 
1.4.1. Co-cultures of ECs with pericytes 
Pericytes have been recently described as CD146+ CD34- cells; however, these 
markers are not reliable in vitro and functional assays are needed (83). These cells were 
considered a multipotent subpopulation of mesenchymal stem cells, being able to retain 
endothelial tubules over time and to stabilize endothelial networks on Matrigel (83). 
Pericytes have been investigated in co-culture systems with endothelial cells to mimic 
the blood brain barrier (84, 85), or the gliovascular complex from the neurovascular unit 
(86), as well as the retinal microvascular environment to study diabetic retinopathy (87). 
Although pericytes are described as being capable of protecting the blood brain barrier 
from disruption, for instance, following short periods of hypoxia (84), works in the field of 
vascularization are still scarce. Some authors developed in vitro models of the 
gliovascular complex and reported that capillary-like structures are maintained over time 
due to the presence of pericytes in co-cultures of endothelial cells and astrocytes (86), 
but pericytes are not the focus of these research models. 
On the other hand, the 10T1/2 cell system, a mouse embryonic cell line, has been 
used as a precursor of pericytes or SMCs, since their differentiation can be induced by 
TGF-β (88). By co-culturing these cells with HUVECs, TGF-β produced by HUVECs 
induced the differentiation of 10T1/2 into pericytes and pericytes were shown to produce 
VEGF, stimulating ECs to organize into capillary-like structures, with markers of activated 
pericytes, like aminopeptidase N, being detected after the first 24h of culture (88). 
The same pericyte precursors were also used by Au et al. to investigate whether the 
implantation of higher cell densities of cord blood(CB)-derived EPCs could obviate the 
need for co-implantation (89). Although some of the implanted CB-EPCs aligned into 
blood vessels, these vessels were only transiently perfused and regressed after 23 days, 
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with 10T1/2 cells functioning as perivascular cells in vivo (89). Therefore, co-implantation 
of endothelial and perivascular cells has been demonstrated to be critical for in vivo 
capillary formation, maintenance and stability. Despite the fact that vascularization starts 
with capillaries and progressively increases complexity in terms of cell organization, co-
culture models have been focusing on cells that are mainly present in large vessels, 
instead of aiming to understand the role of pericytes in supporting vascularization. 
Therefore, further studies are needed, in order to standardize protocols concerning the 
use of a true pericyte and to use these cells for tissue engineering. 
 
1.4.2. Co-cultures of ECs with smooth muscle cells 
SMCs are known to be involved in the stabilization and maturation of blood vessels, 
being crucial for the development of functional blood vessels. A recent study has shown 
that implantation of decellularized small intestinal mucosa scaffold reseeded with 
HUVECs and SMCs resulted in a rapid vascularization (4 days) of the graft, together with 
the maintenance of favorable mechanical properties of the tissue engineered vascular 
grafts (90). 
Co-administration of ECs and SMCs has been investigated in models of ischemia. 
For instance, Foubert et al. implanted endothelial and smooth muscle progenitor cells 
(OECs and SMPCs, respectively) in combination into an ischemic leg of nude mice and 
verified that this combined administration resulted in a higher microvascular density, 
compared to OECs implanted alone (91). In addition, molecular events that are involved 
in vascularization steps appear also seem to be different in co-culture systems, 
compared to ECs cultured alone. For instance, PDGF-B, a factor involved in mural cell 
recruitment, was found to be downregulated over time in co-culture spheroids of 
HUVECs/SMCs, contrasting to HUVECs alone, which suggests that co-cultures properly 
mimic the in vivo phenotype (92), since expression of PDGF-B is believed to be restricted 
to immature capillaries. Also, the Ang1/Tie-2 system regulates both vascular quiescence 
and angiogenesis. Foubert et al. have demonstrated the involvement of these signaling 
partners in the formation of capillary-like networks in co-cultures. In fact, SMPCs 
released Ang-1 and its receptor Tie-2 was subsequently activated in OECs, showing that 
paracrine release of Ang-1 modulate OEC incorporation into the vascular endothelium 
(91).  
Given that OECs are thought to exhibit better characteristics in what concerns to 
vascularization in tissue engineering, Melero-Martin and colleagues first demonstrated 
the in vivo vasculogenic potential of OECs by performing a co-implantation protocol of 
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OECs from the cord blood or from the adult peripheral blood together with SMCs in 
Matrigel plugs by subcutaneous injection into immunodeficient mice (26). This approach 
resulted in the formation of human EC-lined vessels, which contained murine 
erythrocytes, with functional anastomoses being observed (26). They have shown that 
blood vessel formation occurred only for co-implantation experiments (26), reinforcing 
the importance of cellular crosstalk.  
 
1.4.3. Co-cultures of ECs with fibroblasts 
As previously mentioned, the role of fibroblasts in tissue regeneration has somehow 
been underestimated in tissues other than skin (93). However, in the past decade, 
different works have focused on the potential of fibroblasts to enhance vascularization 
and EC assembly into tubular structures. The implantation of neonatal human dermal 
fibroblasts using Matrigel plugs in mice showed that fibroblasts induced the ingrowth of 
blood vessels from the host vasculature (93), thus suggesting that these cells take part 
in the recruitment of ECs in vivo. A combination of fibroblast-derived proteins, comprising 
Ang-1, angiogenin, hepatocyte growth factor, TGF-α and tumor necrosis factor (TNF), 
has been described to support EC sprouting, while matrix proteins, such as collagen I, 
secreted protein acidic and rich in cysteine (SPARC) and insulin-like growth factor-
binding protein 7 (IGFBP7), among others, were necessary for lumen formation in 3D 
fibrin gels, which proved to be related to an increased matrix stiffness (76). In particular, 
when ECM synthesis by fibroblasts is reduced, EC tube formation decrease, although 
ECM synthesis seems not sufficient for the organization of capillary-like structures, which 
requires a close association between ECs and living fibroblasts (61). It has also been 
described that pericytes spontaneously originate from fibroblasts, when co-culture 
systems with ECs are established (81). Berthod et al used a human tissue engineered 
skin model to perform co-cultures of ECs and fibroblasts, showing that cells expressing 
α-SMA only appeared around capillary-like structures, which reinforces the role of 
fibroblast-derived pericytes as supporting cells in vessel formation (81). In addition, a 
spheroid co-culture model has demonstrated that ECs were capable of attaching and 
migrating along fibroblasts-derived ECM into spheroids in order to form a capillary-like 
network (62). Other work reported a rapid sprouting of HUVECs seeded on microcarrier 
beads and co-cultured with dermal fibroblasts, in which capillary-like networks formed in 
a fibrin-based tissue construct after 2-3 days and continued to remodel up to 14 days 
(2). On the other hand, when neonatal human dermal fibroblasts were immobilized in 
alginate gels grafted with RGD peptidic sequence and co-cultured with HUVECs, it was 
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observed that fibroblasts had the ability to modulate and support the assembly of ECs 
into capillary-like structures (94). 
In addition, the simultaneous use of bioactive silicate materials together with co-
cultures of fibroblasts and HUVECs resulted in an enhanced formation of highly 
anastomosed capillary-like structures, with calcium silicate extracts inducing VEGF 
expression by fibroblasts (95).  
Another relevant aspect is the contribution of OECs to accelerate wound healing for 
skin applications. In fact, OECs integrated into dermal fibroblast layers were capable of 
actively incorporating into new blood vessels, promoting re-oxygenation of the wound 
bed (96).  
The implantation of fibroblasts in co-culture with OECs using 3D tissue constructs 
has also been described. Chen and colleagues created prevascularized tissue 
constructs by mixing endothelial cells and fibroblasts in a fibrinogen solution polymerized 
through the addition of thrombin (97). After OECs being organized into capillary-like 
networks in vitro, fibrin-based tissue constructs were implanted, with blood perfusion and 
the formation of anastomosis between vessels from the implanted structure and the host 
vasculature being observed within 27h after implantation, when OECs were co-cultured 
with a high density of fibroblasts (98). 
Considering these data altogether, further studies should be performed using co-
cultures of OECs and fibroblasts, in order to understand the molecular mechanisms 
underlying this cellular crosstalk during the angio- /vasculogenic processes. 
 
1.6 Hypothesis and objectives  
Since activation and migration of fibroblasts is required for several physiological 
events that rely on angiogenesis, the hypothesis underlying the research reported in the 
present work is that outgrowth endothelial cells and mature endothelial cells respond 
differently when co-cultured with different types of fibroblasts, in what concerns the 
formation of capillary-like structures. 
 
In vitro work was performed in order to accomplish the following objectives: 
 To isolate and characterize populations of outgrowth endothelial cells and to 
evaluate their angiogenic potential; 
 To investigate the ability of two types of human dermal fibroblasts to induce/ 
support the formation of vascular-like networks by macrovascular endothelial 
cells and outgrowth endothelial cells; 
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 To characterize the extracellular matrix that is being produced over time in these 
co-culture systems. 
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CHAPTER II  
 
 
 
MATERIALS AND METHODS 
 
 
 
 
2.1. Cell culture  
 
2.1.1. Isolation and expansion of human outgrowth endothelial cells  
Umbilical cord blood (UCB) samples were collected from healthy donors from 
Hospital de São João (Porto, Portugal). All samples were obtained under informed 
consent, according to the Declaration of Helsinki and to the ethical committee of Hospital 
de São João. UCB (volume of 80-100 mL/ isolation) was collected using blood bags 
(Mollitia, Fig. 2.1A) and processed as soon as possible after baby delivery (within an 
hour, at maximum).  
Human OECs were isolated from cord blood samples, according to protocols already 
established (99). UCB was first diluted 1:1 (v/v) in Hank’s Balanced Salt Solution (HBSS, 
Sigma) and overlaid onto Histopaque-1077 solution (Sigma) for separation of 
mononuclear cells (MNCs). After centrifugation, the MNCs fraction was collected from 
the buffy coat layer (Fig. 2.1B) and washed with HBSS. After another centrifugation step 
at 300g for 10 min, the supernatant was discarded and cells were resuspended in 
Microvascular Endothelial Cell Growth Medium-2 (EGM-2MV, Lonza) supplemented with 
10% (v/v) inactivated fetal bovine serum (FBS, Sigma) and centrifuged again for 7 min. 
Finally, MNCs were platted in type I collagen-coated 6-well tissue culture plates (BD, 
Biosciences) in a cell density of 10x106 cells/well. After 24h, wells were washed with 
phosphate buffered saline (PBS) and nonadherent cells were discarded, while adherent 
cells were cultured again in EGM-2MV supplemented with 10% FBS. The medium was 
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changed every other day until colonies with a cobblestone-like morphology appeared, 
which took up to 2 – 3 weeks. These cells, the so-called OECs, were collected and 
expanded over several passages and characterized through imaging flow cytometry, 
immunocytochemistry and western blot. For each experiment, OECs were used at 
passages 2-4. 
 
 
 
Figure 2.1. Isolation of OECs from umbilical cord blood. (A) Blood bag used to collect umbilical cord 
blood after baby delivery. (B) Schematic representation of the separation of blood elements using 
Histopaque-1077. Erythrocytes and granulocytes form a red pellet at the bottom of the centrifuge tube; MNCs 
form a fine band at the interface between Histopaque-1077 and plasma, which appears at the top of the 
tube. 
 
 
2.1.2. Culture of HUVECs 
Human umbilical vein ECs (HUVECs) were kindly provided by Professor James 
Kirkpatrick from REPAIR-lab (University of Mainz, Germany) after being isolated as 
previously described (100). These cells were cultured in Endothelial Cell Growth 
Medium-2 (EGM-2, Lonza) supplemented with 5% (v/v) inactivated FBS (Sigma) and 
maintained in a humidified atmosphere with 5% CO2 – 95% air at 37ºC and medium was 
changed twice a week until 90% confluence was reached, when cells were trypsinized 
and a split ratio of 1:3 was performed. For each experiment, HUVECs were used at 
passages 2-4. 
 
2.1.3. Culture of fibroblasts 
Neonatal human dermal foreskin fibroblasts-1 (HFF-1) were obtained from American 
Type Culture Collections (ATCC) and cultured according to supplier’s instructions. 
Juvenile human dermal fibroblasts (HDF) were kindly provided by Professor James 
Kirkpatrick from REPAIR-lab (University of Mainz, Germany).  
Both types of fibroblasts were cultured in Dulbecco’s Modified Eagle Medium 
(DMEM, Sigma) supplemented with 15% (v/v) inactivated FBS (Sigma) and 1% (v/v) 
antibiotic/antimycotic solution (AB/AM, Sigma). Cells were maintained at 37ºC in a 
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humidified 5% CO2 atmosphere and medium was changed twice a week until 90% 
confluence was reached, when cells were trypsinized and a split ratio of 1:3 - 1:5 was 
performed (94). For each experiment, fibroblasts were used at passages 8-10. 
 
2.2. Characterization of OECs by imaging flow cytometry 
To characterize OECs through imaging flow cytometry, cells were seeded in 0.2% 
(m/v) gelatin-coated 25 cm2 flasks and cultured in EGM-2MV until 90% confluence was 
reached, when cells were trypsinized and counted. Cells were manipulated in 
suspension and, therefore, centrifugation steps (1200 rpm for 5 min) were performed 
between every incubation and washing steps. Cells were washed in PBS, fixed with 4% 
(v/v) of paraformaldehyde (Sigma) and permeabilized with 0.2% (v/v) Triton-X 100 
(Merck) in PBS. After, cells were stained against CD31 (mouse anti-human CD31, Dako, 
1:100), CD34 (mouse anti-human CD34, Dako, 1:50), CD144 (mouse anti-human 
CD144, BD Pharmingen, 1:100) and Flk-1 (mouse anti-human Flk-1, Santa Cruz 
Biotechnology, 1: 200). Alexafluor 488 goat anti-mouse (BD Pharmingen, 1:1000) was 
used as the secondary antibody. Samples were analyzed on imaging flow cytometer 
ImageStream® (Amnis), acquiring at least 10000 events. The data was analyzed using 
the IDEAS® software (Amnis). 
 
2.3. Assembly of OECs into capillary-like structures by Matrigel assay 
In order to evaluate the capacity of OECs to organize into capillary-like structures, a 
Matrigel assay was performed. For this, 200 µL of Growth Factor Reduced Basement 
Membrane Matrix (GFR-Matrigel, BD Biosciences) were added to a 24-well culture plate 
and incubated at 37ºC for 30 min, to allow for Matrigel to solidify. Then, 2x104 of OECs 
in 500 µL of EGM-2MV were added per well. After, wells were maintained at 37ºC in a 
humidified 5% CO2 atmosphere. The cells were monitored using an inverted light 
microscope, to observe the appearance of capillary-like structures, which were then 
counted. 
 
2.4. Direct contact co-cultures of endothelial cells and fibroblasts 
To evaluate the influence of fibroblasts in the ability of endothelial cells to form 
capillary-like structures, single-cell suspensions were seeded as mixtures. Co-cultures 
of ECs (HUVECs or OECs) with fibroblasts (HFF-1 or HDF) were established using a 
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cell ratio of 2:1. Cells were seeded onto 0.2% (m/v) gelatin-coated glass coverslips on 
24-well (2x104 ECs: 1x104 Fibroblasts) and 6-well (2x105 ECs: 1x105 fibroblasts) plates 
coated with 0.2% (m/v) gelatin (Merck) for immunofluorescent staining and protein 
extraction, respectively. ECs and fibroblasts were seeded at the same time to the culture 
plate and were grown in EGM-2 culture media. Different time points were considered – 
7, 14 and 21 days. After each time point, cells were fixed and immunostained as 
described below. Co-cultures were then observed under a confocal microscope (CLSM, 
Leica SP2 AOBS; Leica Microsystems), photographed and parameters as the number 
of capillary-like structures, length, thickness and the number of branching points were 
determined. 
 
2.5. Characterization of cell phenotype and ECM by immunocytochemistry 
For characterizing cells by immunofluorescence, the following primary antibodies 
were used: mouse anti-human CD31 (Dako, 1:100), rabbit anti-human vWF (Dako, 
1:8000), mouse anti-human CD34 (Dako, 1:50), mouse anti-human CD144 (VE-
cadherin, BD Pharmingen, 1:100), mouse anti-human Flk-1 (VEGFR2, Santa Cruz 
Biotechnology, 1: 200), mouse anti-human α-SMA (Dako, 1:100), mouse anti-human 
podoplanin (Santa Cruz Biotechnology, 1:100). For evaluating the distribution and 
organization of the extracellular matrix, mouse anti-human collagen IV (Dako, 1:100), 
mouse anti-human fibronectin (Antibody Shop, 1:200), rabbit anti-human laminin (Sigma, 
1:1000) and mouse anti-human collagen I (abcam, 1:2000) were used. Alexafluor 488 
goat anti-mouse (BD Pharmingen, 1:1000) and Alexafluor 555 donkey anti-rabbit (BD 
Pharmingen, 1:1000) were used as secondary antibodies. All antibodies were diluted in 
1% (m/v) bovine serum albumin (BSA, nzytech) /PBS. 
After being cultured for specific times, cells were fixed with 4% (v/v) of 
paraformaldehyde (Sigma) for 30 min at room temperature. 0.2% (v/v) Triton-X 100 
(Merck) in PBS was used for cell permeabilization. Cells were washed in PBS and 
incubated for 1h at room temperature with primary antibodies. After washing three times 
with PBS, cells were incubated for 1h at room temperature with the secondary 
antibodies. Cell nuclei were then counterstained with 1µg/mL DAPI (Roche) in PBS for 
15 min. Finally samples were washed with PBS and examined by fluorescence 
microcopy (Axio Zeiss Observer Z.1, USA). 
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2.6. Protein extraction 
For protein extraction, cells were trypsinised, centrifuged and suitable amounts of 
RIPA buffer (RIPA buffer 10x, Millipore, diluted 1:10 in Millipore water; phosphatase 
inhibitor cocktail, Sigma and complete protease inhibitor cocktail, Roche) were added to 
the cell pellets on ice. After recovering the supernatant, a BCA (bicinchoninic acid) 
protein Assay Reagent Kit (Pierce, Thermo Scientific) was used to determine the protein 
concentration according to the manufacturer’s protocol. Proteins were quantified using a 
microplate reader (Thermo, Electron Corporation) at 550 nm. 
 
2.7. Western blot analysis for cell characterization and ECM components 
quantification 
For cell characterization, the following primary antibodies were used: rabbit anti-
human β-actin (abcam, 1:3000), rabbit anti-human CD31 (abcam, 1:1000), mouse anti-
human α-SMA (Dako, 1:1000), mouse anti-human podoplanin (Santa Cruz 
Biotechnology, 1:1000), rabbit anti-human transglutaminase-2 (Genetex, 1:1000), rabbit 
anti-human Flk-1 (VEGFR2, Cell Signaling, 1:1000) were used. For quantifying ECM 
components, mouse anti-human collagen IV (Dako, 1:500) and rabbit anti-human laminin 
(Sigma, 1:1000) were used. β-actin was used as an internal control. Goat anti-rabbit IgG 
HRP (Santa Cruz Biotechnology, 1:2000), goat anti-mouse IgG HRP (Santa Cruz 
Biotechnology, 1:2000), donkey anti-rabbit IgG-B (Santa Cruz Biotechnology, 1:2000) 
and goat anti-mouse IgG-B (abcam, 1:2000) were used as secondary antibodies. 
Proteins were separated according to their molecular weight using SDS 
polyacrylamide gel electrophoresis (SDS-PAGE). For that, approximately 10 µg of cell 
proteins were mixed with loading buffer (250 mM Tris-HCl pH 6.8, 8% SDS, 40% 
Glycerol, 0.04% Bromophenol blue (1:4) and dithiothreitol (DTT 1M, 1:20)), being then 
denatured at 99ºC for 1 min. After, samples were loaded into the wells of the stacking 
gel and protein separation was performed at 200 V in SDS-running buffer (125 mM Tris 
HCl pH 8.3, 96 mM Glycine, 0.5% SDS). Precision Plus ProteinTM Dual Color Standards 
(Bio-Rad) were used as protein standards. In order to make the proteins accessible for 
antibody detection, separated proteins were transferred from the gel onto a nitrocellulose 
membrane (Amersham Biosciences), using a mini transfer chamber filled with SDS 
transfer buffer (25 mM Trizma, 192 mM glycine, 20% methanol) for 1h at 40 V. 
Subsequently, the membrane was blocked in blocking solution for 1h at room 
temperature, washed 6 times with TBS 0.05% Tween (TBST) for 5 min and incubated 
with the primary antibody overnight at 4ºC. After another washing step of 6 times with 
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TBST for 5 min, each membrane was incubated with the secondary antibody for 1h at 
room temperature. All antibodies were diluted in the blocking solution.  
For detecting proteins with lower expression, membranes were incubated with avidin-
biotin complex solution (VECTASTAIN ABC kit PK-6100, Vector Laboratories) for 30 min. 
Antibodies were detected using enhanced chemiluminescent (ECL) reagents (GE 
Healthcare) and the membranes were visualized using ChemiDocTM MP System (Bio-
Rad). Images were acquired and western blots were quantified using Image Lab 
Software 4.0.1 (Bio-Rad). Each sample was assayed three times in separate gels. 
Results are presented as relative protein expression normalized to signal intensity of β-
actin protein.  
 
2.8. Preparation of fibroblast conditioned media 
Fibroblasts (either HFF-1 or HDF) were cultured in DMEM (Sigma) supplemented 
with 15% (v/v) FBS (Sigma) and 1% (v/v) AB/AM solution (Sigma) until 70% confluence 
was reached. Then, media was removed and cells were washed in PBS. Conditioned 
culture media was obtained by culturing fibroblasts during 24h in EBM-2 (Basal Medium) 
supplemented with 5% (v/v) FBS (Sigma) and 1% (v/v) AB/AM solution (Sigma). Medium 
was collected, centrifuged at 1200 rpm for 5 min. and the supernatant was harvested at 
-20ºC.  
 
2.9. Determination of metabolic activity by MTS assay 
Endothelial cells (HUVECs and OECs) were separately plated at a density of 6x104 
mL-1, left to adhere for 24h and, then, cultured in fibroblast conditioned media (CM) using 
a final volume of 100 μL. Different percentages of CM were used – 25, 50, 75 and 100%. 
Fresh culture medium was used to complete the volume. After 24h, a colorimetric method 
was used to evaluate EC metabolic activity (CellTiter 96R AQueous One Solution Cell 
proliferation Assay, Promega), according to supplier’s instructions. The absorbance was 
measured at 490 nm in a plate reader (Thermo, Electron Corporation). The quantity of 
formazan product as measured by this absorbance is directly proportional to the number 
of living cells in culture. 
 
2.10. Co-cultures of endothelial cells and fibroblasts in Matrigel 
HDF were cultured for 24h at a cell density of 10000 cells/well in a 24-well plate. 
Matrigel assay was performed similarly to the assay previously described. Here, 200 
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µL/well of GFR-Matrigel (BD Biosciences) were added to the top of the fibroblast 
monolayer. Then, 60000 endothelial cells were added per well and cultured in 500 µL of 
EGM-2 culture medium. Controls were established by omitting fibroblasts from the 
experimental setup (Fig. 2.2). During the experiment, cells were monitored and 
photographed using an inverted light microscope, to observe the appearance of capillary-
like structures. The number of capillary-like structures, length, thickness and the number 
of branching points were also evaluated. 
 
 
 
Figure 2.2. Experimental design for co-culturing endothelial cells and fibroblasts in Matrigel.  
 
2.11. Imaging and image quantification 
Cell morphology and adhesion were monitored daily using an optical microscope. 
Cell characterization by immunofluorescence was analyzed using a Carl Zeiss Axiovert 
inverted microscope. Monocultures and co-cultures were visualized and scanned under 
a Leica confocal microscope (CLSM, Leica SP2 AOBS; Leica Microsystems) using laser 
wavelengths of 405 nm (DAPI), 488 nm (green) and 561 nm (red). Image analysis 
software ImageJ64 was used for quantifications, including the length and diameter of 
capillary-like structures. 
 
2.12. Statistical analysis 
All experiments were performed in triplicate. Quantifications are expressed as mean 
± standard deviation (SD). The Student’s t-test was used for comparisons between two 
groups. A difference between experimental groups was considered significant with a 
confidence interval of 95%, whenever p<0.05. 
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CHAPTER III 
 
 
 
RESULTS 
 
 
 
 
3.1 Endothelial phenotype of OECs from umbilical cord blood 
Outgrowth endothelial cells (OECs) were isolated from human umbilical cord blood 
and appeared after 2-3 weeks as small colonies in monocultures of MNCs, developing a 
characteristic cobblestone-like morphology over time (Fig. 3.1), similarly to endothelial 
cells, as well as showing a high proliferative potential. These cells were characterized in 
terms of the expression of endothelial markers, including CD31, VE-cadherin and vWF, 
as well as VEGFR2 and CD34 (Fig. 3.2A). CD31 and VEGFR2 expression was also 
verified at the protein level (Fig. 3.2B). These cells expressed significant levels of CD31 
and VEGFR2, identical to β-actin, housekeeping gene. The presence of CD31 and 
VEGFR2 markers confirms that OECs are an endothelial cell population, while CD34 
confirms that these cells have a mesodermal origin and that they are still in an endothelial 
progenitor cell state. 
 
 
 
Figure 3.1. Morphology of outgrowth endothelial cells in culture. Here, at day 10, OECs are 
differentiating as colonies and at day 21 cells are confluent in the well, exhibiting a cobblestone-like 
phenotype. Scale bar, 100 μm.  
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Figure 3.2. Immunophenotypic characterization of OECs. (A) Characterization of OECs by 
immunocytochemistry. OECs stained positive for CD31 (green), vWF (red), CD34 (green), VEGFR2 (green) 
and VE-cadherin (green). Nuclei are counterstained with DAPI (blue). Scale bars, 100 μm. (B) Expression 
of CD31 and VEGFR2 in OECs determined by western blot analysis. Relative protein expression was 
obtained through normalization to signal intensity of β-actin protein (n=3). 
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Table 3.1 summarizes the percentage of cells expressing CD31, CD34, VE-cadherin 
and VEGFR2, with over 99% of the cells used in this study staining positive for CD31 
and VEGFR2, while approximately 91% of this cell population was positive for CD144 
(VE-cadherin). The overall expression of CD34 was markedly lower than the expression 
of the other cell markers, with only approximately 33% of this cell population staining 
positive for CD34. 
 
 
Table 3.1. Phenotypic characterization of OECs by imaging flow cytometry. OECs were immunostained 
against CD31, CD34, CD144 (VE-cadherin) and VEGFR2. The percentage of positive cells was calculated 
according to the gate defined for the unstained controls. 
 
 
 
In addition, by establishing a relation between the median pixel (a measure of signal 
strength) and a texture feature, the gradient RMS, imaging flow cytometry allowed to 
characterize this cell population in terms of the cellular distribution of the different studied 
markers.  
Indeed, OECs used in the present study appeared to constitute an heterogeneous 
population, making possible to define two to six distinct regions, according to the cellular 
distribution and intensity of each marker (R1-R6, Fig. 3.3). The population of CD31+ cells 
(Fig. 3.3A), as well as CD34+ cells (Fig. 3.3B), could be divided into six regions (R1-R6), 
with the expression of both surface markers varying from an homogeneous distribution 
with low intensity (R1) to an heterogeneous distribution with high intensity (R6). On the 
other hand, the expression of VE-cadherin (CD144, Fig. 3.3C) and VEGFR2 (Fig. 3.3D) 
could only be divided into a region of homogeneous distribution with low intensity (R1) 
and a region of heterogeneous distribution with low intensity (R2), although a single 
CD144+ cell appeared with a higher intensity (R6, Fig. 3.3C). 
Considering these characterization data together, it is possible to define OECs used 
here as an heterogeneous cell population, expressing relevant EC markers, like CD31, 
vWF, VE-cadherin, VEGFR2 and, to a lower extent, CD34. 
 
 
 
 
 
OECs 
 CD31 CD34 CD144 VEGFR2 
Positive (%) 99.79 33.48 91.39 99.3 
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Figure 3.3. Characterization of the phenotypic heterogeneity of OECs by imaging flow cytometry in 
terms of the positive expression of CD31, CD34, CD144 and VEGFR2. Results presented here correspond 
to a relation between the median pixel (signal strength feature) and the gradient RMS (texture feature). 
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In addition, GFR-Matrigel™ assay was performed in order to evaluate the ability of 
OECs to assemble into capillary-like structures, as this is another endothelial 
characteristic. Indeed, OECs were capable of organizing into typical polygonal structures 
(Fig. 3.4A). This was observed as soon as 6h after OECs being seeded on top of a GFR-
Matrigel™ layer and these capillary-like structures were maintained at least until 48h of 
culture, with a decrease in their number being observed over time (Fig. 3.4B). 
 
 
 
Figure 3.4. Assembly of OECs into capillary-like structures in Matrigel. (A) Microscopic image of 
capillary-like structures formed by OECs after 24h in Matrigel. Scale bar, 100 μm. (B) Number of capillary-
like structures/cm2 formed by OECs in Matrigel after 6, 24 and 48h. 
 
 
3.2 Effect of different culture media in EC metabolic activity  
In order to determine the influence of different culture media in the metabolic activity 
of endothelial cells, an MTS assay was performed. For that, EGM-2 and EGM-2MV were 
prepared according to manufacturer’s instructions and supplemented with 5% and 10% 
FBS, respectively. After 24h in culture, no differences were observed between the 
behavior of both types of ECs cultured either in EGM-2 or EGM-2MV (Fig. 3.5). In order 
to facilitate the comparison with other works, EGM-2 culture medium was selected to 
perform the subsequent angiogenesis assays, as it is widely used for establishing 
different co-culture systems aiming for vascularization. 
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Figure 3.5. EC metabolic activity in response to different culture media. Relative metabolic activity of 
OECs and HUVECs in response to different culture media by MTS assay, after 24h (n=3).  
 
3.3 Characterization of fibroblasts 
For the establishment of a co-culture system, two types of human dermal fibroblasts 
were used, HFF-1 and HDF. Therefore, fibroblasts were characterized using different 
markers. The expression of podoplanin (PDPN) was investigated as a marker of dermal 
fibroblasts and, when monocultures of HFF-1 and HDF were performed using DMEM 
and EGM-2, it was observed that both types of fibroblasts expressed PDPN after 24h in 
culture (Fig. 3.6A). Besides, the expression of markers of fibroblast activation, like α-
SMA, was also studied. In figure 3.6B, it was observed that both fibroblasts, when 
cultured alone in EGM-2, exhibited a lower expression of α-SMA after 7 days. However, 
after 21 days, it was possible to observe an increase in the expression of α-SMA, mainly 
in the case of HDF (Fig. 3.6B). 
In addition, western blot analysis was performed to evaluate the expression of PDPN 
and α-SMA at the protein level, as well as to investigate the expression of other dermal 
fibroblast marker, transglutaminase-2 (TG2), in monocultures of HFF-1 and HDF after 7, 
14 and 21 days in EGM-2 (Fig. 3.6C). It was verified that both types of fibroblasts 
expressed all proteins. Nonetheless, HFF-1 exhibited a higher expression of TG2 than 
that observed for HDF, while HDF expressed higher amounts of PDPN and α-SMA. 
Furthermore, there was a significant increase in the expression of PDPN between day 7 
and day 14, as well as an increase of α-SMA expression from day 7 to day 21 in HDF 
monocultures. 
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Figure 3.6. Characterization of fibroblasts. (A) Fluorescence microscope images of fibroblasts (HFF-1 
and HDF) expressing podoplanin (green) after 24h in culture both in DMEM and in EGM-2 (scale bar, 200 
μm). (B) Confocal images of fibroblasts (HFF-1 and HDF) expressing α-SMA (green) after 7 and 21 days in 
culture in EGM-2 culture medium (scale bar, 200 μm). (C) Western blot and quantitative analysis of 
transglutaminase-2 (TG2, n=3), podoplanin (PDPN, n=3) and α-SMA (n=1) expressed by fibroblasts after 7, 
14 and 21 days. * Statistically significant differences (p<0.05), between time points. # Statistically significant 
differences (p<0.05), compared to HFF-1. 
 
 
 
3.4 Fibroblasts influenced EC assembly into capillary-like structures 
A co-culture system of ECs (HUVECs and OECs) with fibroblasts (HFF-1 and HDF) 
was established to assess the capacity of different fibroblasts to support the formation of 
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capillary-like structures by ECs. HUVECs and OECs were cultured alone to serve as 
controls.  
Figure 7 shows the behavior of HUVECs in a monoculture (Fig. 3.7A-C) and in co-
culture systems with HFF-1 (Fig. 3.7D-F) and HDF (Fig. 3.7G-I). Here, it was observed 
that co-culturing HUVECs with HDF resulted in the formation of a capillary-like network 
after 14 days in culture (Fig. 3.7H), which was maintained at least after 21 days (Fig. 
3.7I), with an interconnected network with luminal structures being observed (Fig. 3.8). 
The same was not observed when HFF-1 were used in the co-culture system, with 
HUVECs organizing into clusters (Fig. 3.7D-F), although with some protuberant tubular-
like structures after 14 (Fig. 3.7E) and 21 (Fig. 3.7F) days. In the control condition, 
HUVECs stayed in a monolayer over time (Fig. 3.7A-C). 
 
 
Figure 3.7. Co-cultures of HUVECs with fibroblasts. Confocal images of HUVEC alone (A-C), co-cultures 
of HUVEC/HFF-1 (D-F) and HUVEC/HDF (G-I) after 7, 14 and 21 days in EGM-2. HUVECs were stained 
against CD31 (green) or vWF (red) and nuclei were counterstained with DAPI (blue). Scale bar, 200 μm. 
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Figure 3.8. Luminal structures in co-cultures of HUVEC/HDF. Confocal image of lumen formation in an 
interconnected microvascular-like network in co-cultures of HUVEC/HDF after 21 days. HUVECs were 
stained against CD31 (green) and nuclei were counterstained with DAPI (blue). Scale bar, 50 μm. 
 
 
 
OECs were also used in these co-culture systems (Fig. 3.9). When using HFF-1, 
OECs organized into clusters (Fig. 3.9D-F), whereas when co-cultured with HDF, OECs 
assembled into capillary-like structures after 14 days (Fig. 3.9H), which were maintained 
after 21 days in culture (Fig. 3.9I). This is similar to the previously described behavior for 
HUVECs. When cultured alone, OECs organized into a typical cell monolayer (Fig. 3.9A-
C). 
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Figure 3.9. Co-cultures of OECs with fibroblasts. Confocal images of OEC alone (A-C), co-cultures of 
OEC/HFF-1 (D-F) and OEC/HDF (G-I) after 7, 14 and 21 days in EGM-2. OECs were stained against CD31 
(green) and nuclei were counterstained with DAPI (blue). Scale bar, 200 μm. 
 
 
In addition, figure 10 shows a comparison between the ability of HUVECs and OECs 
to assemble into capillary-like networks in a co-culture system with HDF. Here, it is 
observed that both types of ECs started organizing into capillaries after 7 days in co-
culture with HDF (Fig. 3.10A, 3.10D). HUVEC/HDF co-cultures resulted in the formation 
of capillaries (Fig. 3.10A-C) in a higher extent than those originated in OEC/HDF co-
cultures (Fig. 3.10D-F). Although OECs assembled into structures with a characteristic 
tubular aspect, HUVECs, on the other hand, were able to organize into a highly 
branched, interconnected capillary-like network. 
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Figure 3.10. Comparison between HUVEC/HDF and OEC/HDF co-cultures. Fluorescence microscope 
images of co-cultures of HUVEC/HDF (A-C) and OEC/HDF (D-F) after 7, 14 and 21 days. HUVECs and 
OECs were stained against CD31 (green) and nuclei were counterstained with DAPI (blue). Scale bar, 500 
μm. 
 
 
 
 
 
Therefore, to assess the evolution of this HUVEC-derived capillary-like network over 
time, parameters including the number of capillary-like structures and branching points, 
as well as the diameter and length of the capillary-like structures were determined in co-
cultures of HUVEC/HDF, after 14 and 21 days (Fig. 3.11). Indeed, there was an increase 
in the number of capillary-like structures (p<0.05, Fig. 3.11A) and an enlargement of 
these structures (p<0.05, Fig. 3.11D) from day 14 to day 21. The number of branching 
points (Fig. 3.11B) and the diameter of the capillary-like structures (Fig. 3.11 C) remained 
similar between those two time points. 
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Figure 3.11. Number of capillary-like structures, branching points, length and diameter in 
HUVEC/HDF co-cultures.  Average quantifications of the number of capillary-like structures (A) and 
branching points/mm2 (B), the length (C) and the diameter (D) of capillary-like structures formed in co-
cultures of HUVEC/HDF after 14 and 21 days. * Statistically significant differences (p<0.05, n=6). 
 
 
 
 
3.5 Extracellular matrix production by different cell types 
Fibroblasts are the main producers of extracellular matrix components. To evaluate 
the differences between the ECM produced by distinct types of fibroblasts and 
endothelial cells, immunostainings against collagen types I and IV, fibronectin and 
laminin were performed.  
It was observed that HUVECs secreted collagen IV, fibronectin and laminin to the 
extracellular media, but not collagen I (Fig. 3.12). OECs produced the same ECM 
components at a lower extent and only intracellularly (Fig. 3.12). 
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Figure 3.12. ECM components produced by ECs. Fluorescence microscope images of extracellular matrix 
components – collagen types I (green) and IV (green), fibronectin (green) and laminin (red) – produced by 
endothelial cells (upper panel – HUVEC and lower panel – OEC) after being cultured for 14 days in EGM-2 
culture medium. Nuclei were counterstained with DAPI (blue). Scale bar, 200 μm. 
 
 
Both types of fibroblasts secreted collagen IV, fibronectin and laminin to the 
extracellular media, but only HDF secreted collagen I (Fig. 3.13). 
 
 
Figure 3.13. ECM components produced by human dermal fibroblasts. Fluorescence microscope 
images of extracellular matrix components – collagen types I (green) and IV (green), fibronectin (green) and 
laminin (red) – produced by fibroblasts (upper panel – HFF-1 and lower panel – HDF) after being cultured 
for 14 days in EGM-2 culture medium. Nuclei were counterstained with DAPI (blue). Scale bar, 200 μm. 
 
 
For a better understanding about what happens with the ECM during the formation 
of capillary-like structures, the co-culture of HUVEC/HDF was selected for further 
investigation of the ECM components. Thus, in co-cultures of HUVEC/HDF, it was 
observed that all investigated ECM components were present, with collagen types I and 
IV being mainly expressed where capillary-like structures were present (Fig. 3.14A). 
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Due to their importance in the constitution of basement membranes, collagen IV and 
laminin were also investigated by western blot (Fig. 3.14B). Here, it has been verified 
that collagen IV and laminin were expressed at all time points, although laminin 
expression decreased from day 7 to day 14. 
 
 
 
Figure 3.14. ECM in co-cultures of HUVEC/HDF. (A) Fluorescence microscope images of extracellular 
matrix components – collagen types I (green) and IV (green), fibronectin (green) and laminin (red) –produced 
in co-culture systems of HUVEC and HDF after 14 days in EGM-2 culture medium. Endothelial cells were 
stained against vWF (red) or CD31 (green). Nuclei were counterstained with DAPI (blue). Upper panel, scale 
bar, 200 μm. Lower panel, scale bar, 50 μm. (B) Western blot analysis of collagen IV and laminin expressed 
in co-cultures of HUVEC/HDF after 7, 14 and 21  days in EGM-2 culture medium. 
 
 
 
3.6 EC metabolic activity in response to conditioned media from fibroblasts 
In order to investigate whether the factors produced by the two types of fibroblasts 
affect EC metabolic activity in a paracrine manner, conditioned media from each type of 
fibroblasts (HFF-1 and HDF) were obtained and used for culturing HUVECs and OECs 
separately. This effect was compared with the control fresh medium (EBM-2 
supplemented with 5% FBS and 1% AB/AM). In what concerns to OECs, only the 
condition with 100% conditioned medium (CM) from HFF-1 induced a decrease (p<0.05 
vs control) in the metabolic activity of these cells, in comparison to the control (Fig. 
3.15A). Also, when the percentage of CM from HFF-1 is reduced (higher percentage of 
fresh basal medium), there is a tendency for the metabolic activity of OECs to increase 
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(Fig. 3.15A). In the case of CM from HDF, no changes in the metabolic activity of OECs 
(Fig. 3.15B) were observed.  
On the other hand, HUVECs exhibited no changes in their metabolic activity when 
cultured with different percentages of CM from HFF-1 (Fig. 3.15C) and HDF (Fig. 3.15D). 
When comparing OECs to HUVECs, cells responded differently to conditions 
corresponding to 50% conditioned media both from HFF-1 and HDF, with HUVECs 
exhibiting an increased metabolic activity than that observed for OECs. 
 
 
Figure 3.15. EC metabolic activity in response to conditioned media from fibroblasts after 24h. 
Percent metabolic activity of OECs in response to conditioned media from HFF-1 (A) and HDF (B). Percent 
metabolic activity of HUVECs in response to conditioned media from HFF-1 (C) and HDF (D). * Statistically 
significant differences (p<0.05 vs control, n=3); # Statistically significant differences – Increased metabolic 
activity of HUVECs (p<0.05 vs OECs, n=3). 
 
 
3.7 Assembly of ECs into a 3D microcapillary-like network in Matrigel 
The Matrigel assay was performed to assess if the presence of fibroblasts (HDF) 
would influence the ability of ECs (HUVECs or OECs) to assemble into capillary-like 
structures, as well as to evaluate if these structures could be maintained and stabilized 
over time. The formation of capillary-like structures can be observed in Fig. 3.16A, with 
ECs being organized into characteristic polygonal forms after 24h. In Matrigel, co-
cultures of HUVEC/HDF and OEC/HDF had a similar behavior to that of monocultures 
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of HUVECs and OECs, as seen through the number of capillary-like structures (Fig. 
3.16B) and branching points (Fig. 3.16C) after 24h. In what concerns to length (Fig. 
3.16D) and diameter (Fig. 3.16E) of capillary-like structures, there were no differences 
between HUVEC or OEC-derived structures, although there was a tendency for HUVECs 
to originate larger capillary-like structures. 
After 48h, the previously formed capillary-like structures started to disaggregate in 
the case of HUVECs, almost disappearing after 7 days (Fig. 3.16A), with HUVECs 
adhering to the Matrigel layer. For OECs in monoculture, there seemed to be a higher 
stability of these structures, which were maintained until day 7 (Fig. 3.16A). 
In co-culture conditions, fibroblasts exhibited a high proliferative capacity and 
migrated to the superficial layer of the Matrigel, instead of staying at the bottom of the 
culture well. In the case of HUVEC/HDF, capillary-like structures disassembled over 
time, similarly to the monoculture condition (Fig. 3.16A). However, a different behavior 
can be observed for OEC/HDF, where capillary-like structures were maintained above 
layers of migrating fibroblasts. 
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Figure 3.16. 3D Matrigel assay. (A) Optical microscope images of HUVEC, HUVEC/HDF, OEC and 
OEC/HDF in Matrigel after 24h, 48h and 7 days. Scale bar, 200 μm.  (B) Average number of capillary-like 
structures/mm2; (C) Average number of branching points/mm2; (D) Average diameter of capillary-like 
structures (μm) and (E) Average length of capillary-like structures (μm). B-E were determined after 24h in 
Matrigel (n=6 for co-cultures; n=4 for monocultures). 
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CHAPTER IV 
 
 
 
DISCUSSION 
 
 
 
Over the years, different strategies have been described aiming to achieve the 
vascularization of an engineered tissue, including cell-based therapies. The discovery of 
an endothelial progenitor cell (23) has brought new insights into the field of vascular 
biology and the use of a “true endothelial progenitor cell” could ameliorate strategies 
based on the transplantation of endothelial cells. Despite the controversy that still exists 
about terminology and exact origin, OECs seem to fulfill the main requisites for being 
considered a “true endothelial progenitor cell”: (i) these cells can be easily obtained from 
circulating blood, constituting an autologous source of ECs; (ii) several endothelial 
markers are also expressed by OECs; (iii) they present a high expansion potential in 
culture due to their increased proliferation ability.  
In the present study, human OECs have been isolated from umbilical cord blood to 
analyze their potential contribution for angiogenesis in co-culture systems. These cells 
exhibited a high proliferation capacity in culture and expressed typical endothelial 
markers, such as CD31, vWF, VE-cadherin, VEGFR2 and, to a lower extent, CD34, in 
agreement to past descriptions of this cell population (99). Although CD34 is 
characteristically expressed by vascular ECs (101), some authors have also reported a 
low signal for CD34 both in HUVECs and OECs (102), which is in accordance to the fact 
that CD34+ ECs are enriched for biological functions related to angiogenesis and 
migration, whereas CD34- cells are enriched for functions related to proliferation (103). 
This observation somehow confirms the proliferation state of OECs in monoculture.  
In addition, when the angiogenic potential of OECs used here was tested in a Matrigel 
assay, these cells displayed a good ability for organizing into typical polygonal capillary-
like structures at least for 48h, in accordance to what has been described (104). 
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Since OECs were cultured in EGM-2MV and other works reporting the use of co-
culture systems use EGM-2 (22, 98), an MTS assay was performed in order to compare 
the metabolic activity of ECs (both HUVECs and OECs) in response to these distinct 
culture media. Here, no differences were observed in EC behavior when cultured either 
in EGM-2MV or EGM-2. Therefore, EGM-2 culture medium was selected to perform the 
subsequent angiogenesis assays. 
In what concerns to fibroblasts, these cells have traditionally been associated to 
pathological conditions that involve the development of fibrotic tissue, for instance in 
cardiac diseases (105, 106). Fibrosis consists on a scarring process that results from 
fibroblast accumulation, as well as an excessive and disorganized deposition of ECM 
components (105). However, fibroblasts exhibit pleiotropic functions and are not only 
matrix-producing cells (106). Therefore, due to their production of biochemical mediators 
(e.g. growth factors, cytokines and proteases) and their role in the homeostasis of 
different tissues, fibroblasts have gained increased attention over the years in the field 
of tissue engineering. 
Since fibroblasts are known to be quite different regarding their tissue of origin, one 
of the purposes of the current study was to compare the behavior of two distinct fibroblast 
populations – HFF-1 and HDF. HFF-1 are a commercial population of primary neonatal 
human dermal fibroblasts, whereas HDF constitute a population of primary juvenile 
dermal fibroblasts. Indeed, human dermal fibroblasts were selected based on the fact 
that these cells can be easily isolated from skin and, if being autologous to the patient, 
they carry no risk of rejection or cross-infection (56). 
Dermal fibroblasts can be divided into papillary and reticular fibroblasts, and, as 
previously described by Janson et al., these two cell types might be distinguished by the 
expression of podoplanin (PDPN) and transglutaminase 2 (TG2), respectively (59).   
Different patterns of the expression of PDPN and TG2, as well as of α-SMA were 
found between HFF-1 and HDF. In fact, HFF-1 expressed higher levels of TG2, whereas 
PDPN and α-SMA were expressed in higher amounts in HDF.  
α-SMA is a known marker of activated fibroblast/myofibroblast differentiation. 
Transglutaminase-2 belongs to a group of enzymes that catalyze post-translational 
modification of proteins, through the formation of isopeptide bonds, and is involved in 
biological processes, such as cell death and differentiation, as well as matrix stabilization 
(107). Podoplanin is a mucin-like transmembrane glycoprotein and it has been 
associated to lymphangiogenesis (108). However, there are no studies relating 
podoplanin to angiogenesis during tissue repair or regeneration. 
Considering this data together, it could be hypothesized that HFF-1 would constitute 
a population of reticular fibroblasts, while HDF would correspond to a population of 
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papillary fibroblasts. However, care should be taken when extrapolating this conclusion 
based on the described cell markers, mainly due to the fact that fibroblasts used here 
were not isolated from the same skin donor site and, consequently, are not so easily 
comparable. In addition, a recent work has shown that papillary fibroblasts can 
differentiate into reticular fibroblasts when cultured over several passages (109). Also, a 
noteworthy aspect is that the same authors have attributed a higher expression of α-
SMA to reticular fibroblasts (59, 109), whereas in the populations described here high 
levels of this marker were found to be expressed by HDF.  
Consequently, both types of fibroblasts were used to examine their capacity to 
influence the formation of capillary-like structures either by macrovascular and progenitor 
ECs (HUVECs and OECs, respectively). HDF were found to induce to a high extent the 
formation of capillary-like structures, while HFF-1 failed to promote EC organization into 
tubular structures. Indeed, HDF had the ability to promote the assembly of HUVECs into 
a complex interconnected capillary-like network after 14 days and to support the 
maintenance of this network at least until day 21. In this culture system, the support of 
HDF resulted in a higher number and in an enlargement of HUVEC-derived capillaries 
caliber between days 14 and 21. Identical to its influence in macrovascular ECs, HDF 
also induced OECs to assemble into capillary-like structures for 21 days. 
This difference between the ability of HDF and HFF-1 to induce the formation of 
capillaries in vitro might be due to the fact that HDF expressed markers of papillary 
fibroblasts (PDPN), while HFF-1 expressed markers of reticular fibroblasts (TG2). As 
previously mentioned, it is known that, contrary to papillary fibroblasts, reticular 
fibroblasts seem to have a lower ability to support the formation of tubular-like structures 
in vitro (60). Indeed, TG2 has been described as a partner of endostatin, an anti-
angiogenic peptide present in the ECM close to ECs (110). 
Although ECs are a rich source of TG2 (111), the presence of TG2 produced by the 
HFF-1 might be one of the reasons for the observed inhibition of EC assembly into 
capillary-like structures, as it has already been described that the addition of exogenous 
TG2 blocks angiogenesis in vitro (112). In the present work, HUVECs were found to be 
expressing TG2 when cultured alone for 7, 14 and 21 days (data not shown). However, 
expression of TG2 was not verified when formation of capillary-like structures occurred, 
namely in co-cultures of HUVEC/HDF (data not shown), which corroborates the fact that 
the presence of TG2 produced by fibroblasts (HFF-1) might be an inhibitor of the 
formation of capillary-like structures.  
Nevertheless, previous studies from the same team have shown that when HFF-1 
were entrapped in an artificial extracellular matrix, such as modified alginate with RGD 
peptidic sequence (arginine-glycine-aspartic acid, RGD), the capillary-like structures 
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were maintained during 5 days (94). In addition, when HFF-1 were used in a model of 
Matrigel plug implantation in mice, these cells induced the ingrowth of blood vessels from 
the host vasculature into the plug (93). This raises the question about to what extent can 
a biomaterial modulate the crosstalk between cells in direct contact. Thus, more studies 
at the molecular level will be useful to help clarifying this issue. 
Another hypothesis to explain the distinct behavior of ECs in the described co-culture 
systems is based on distinct profiles of soluble factors or ECM components being 
produced by HFF-1 or HDF. Thus, HUVECs and OECs were cultured with conditioned 
media obtained from both types of fibroblasts, in order to investigate if there was any 
difference on EC metabolic activity in response to factors produced either by HFF-1 or 
HDF. Using MTS assay, it was observed that there were no differences in EC response 
to HDF-conditioned medium. However, conditioned medium from HFF-1 significantly 
reduced OEC metabolic activity, when these cells were cultured without the addition of 
fresh medium (100% CM from HFF-1). Indeed, there was a tendency for OEC metabolic 
activity to increase, when cultured with decreasing percentages of CM from HFF-1. 
Significant differences were also obtained when comparing the response between 
HUVECs and OECs to the conditions that had 50% CM both from HFF-1 and HDF (50% 
fresh medium). 
Since no exogenous growth factors were added to the medium and OECs, as 
microvascular progenitor cells, are more sensitive to the lack of factors, it can be 
hypothesized that the distinct ability of both fibroblasts to support the formation of 
capillaries in vitro may not result from distinct patterns in terms of the secretion of soluble 
factors. 
Sorrell et al. 2008 seeded together papillary and reticular fibroblasts in a dish and 
observed a higher formation of capillary-like structures in the area where papillary 
fibroblasts were present (60). This suggested that either ECM molecules or matrix-bound 
molecules would be critical for the formation of capillary-like structures; otherwise the 
release of factors to the medium would have been sufficient to obtain an homogenous 
formation of tubular structures by ECs.  
Consequently, all cell types used in the present study were further characterized in 
terms of ECM components secretion, including collagen types I and IV, fibronectin and 
laminin. 
One striking difference between HUVECs and OECs is their release of ECM 
components. Accordingly, HUVECs were found to secrete collagen type IV, fibronectin 
and laminin to the extracellular media, whereas in OECs these proteins were only 
detected intracellularly. HUVECs have been described to produce collagen IV, 
fibronectin and laminin only when cultured under hypoxic conditions (113). However, this 
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latter work used shorter time points (1 and 4 days in culture). In the current work, it has 
been shown that macrovascular ECs, namely HUVECs, are also ECM producers not 
only after 14 days as described, but also at day 7 and 21 (data not shown). 
In what concerns to fibroblasts, HDF were able to secrete all the investigated ECM 
components, primarily collagen I, which is lacking in HUVECs, OECs and HFF-1. 
Therefore, the role of HDF as stimulators of the formation of vascular structures probably 
depends on the secretion of these components. 
As the production and deposition of ECM components result in the assembly of a 3D-
like matrix and since cells are naturally embedded in a 3D microenvironment, a 3D 
Matrigel assay was performed to evaluate the behavior of a co-culture system of ECs 
(HUVECs and OECs) with HDF. After 24 and 48h, it was observed that HUVECs and 
OECs had a similar behavior when co-cultured with HDF, with capillary-like structures 
being of a larger caliber in co-culture conditions, compared to ECs alone. Nevertheless, 
after 7 days, capillary-like structures previously formed in HUVEC monocultures 
appeared to be disaggregating and almost disappearing in co-cultures of HUVEC/HDF. 
In the case of progenitor cells, capillary-like structures were still observed both in OEC 
monocultures and in co-cultures of OEC/HDF after 7 days. This result suggests that 
using OECs in a 3D matrix might be a better strategy to promote vascularization. 
However, care should be taken when extrapolating conclusions from these results. 
In the present work, two distinct systems were compared: one in 3D without the addition 
of an external ECM (co-culture) and another in 3D with the addition of an external ECM 
(matrigel) at the beginning of the assay. Despite being a common in vitro 3D assay to 
evaluate tubule formation, GFR-Matrigel results in the formation of short and relatively 
homogeneous capillary-like structures (114). On the other hand, co-cultures of ECs with 
fibroblasts originate a highly heterogeneous network of interconnected capillary-like 
structures, resembling in vivo capillary organization (114). Here, another relevant aspect 
to take into consideration is the time course over which both assays were carried out. 
Longer time points used for performing the 3D co-culture system (14 and 21 days) could 
not be used for Matrigel assay. Indeed, Matrigel would be degraded if extensive time 
points were used, due to the presence of proteases secreted by migrating cells (115).  
Altogether, these findings suggest that HDF is a preferential cell source for enhancing 
vascularization, both in HUVECs and OECs. Given the already described advantages of 
OECs, these findings open a new field of research regarding the use of specific fibroblast 
populations co-cultured with OECs, as efficient partners for vascular development with 
tissue regeneration purposes. Finally, in vivo implantation of OECs together with HDF 
would further elucidate their role in vascular tissue engineering.
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CHAPTER V 
 
 
 
CONCLUSIONS AND PERSPECTIVES  
 
 
 
 
Cellular strategies constitute a promising way to achieve vascularization of tissue 
engineering constructs avoiding the undesirable side effects of growth factor, cytokine, 
hormone or other bioactive molecules delivery. 
The interactions between endothelial cells and other cell types seem to constitute a 
bi-directional system. Co-culture systems are a useful instrument providing new insights 
into the molecular mechanisms underlying vascularization, since they are capable of 
mimicking physiological processes. Cell-cell contacts correspond to a precise 
representation of in vivo tissues, enhancing cell-specific activities. In general, 
microvessel-like structures are formed in these co-culture systems. 
Endothelial progenitor cells have brought new prospects and are currently being 
investigated as a potential cell source for therapeutic applications requiring 
vascularization. OECs in particular are considered an especially interesting source of 
autologous endothelial cells for tissue engineering owing to their high proliferative 
capacity.  
The present work focused on the in vitro formation of capillary-like structures, aiming 
to understand the importance of cell communication in a co-culture system. 
On the one hand, monocultures of OECs and HUVECs have been reported to behave 
similarly in terms of angiogenic activity. On the other hand, different results were 
obtained from co-cultures, with OECs exhibiting an enhanced vessel formation when 
other cell types were present. These results suggest that further investigation should be 
performed at the molecular level to gain insight into such differences. Standard protocols 
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should be established in order to overcome the present limitations, as well as to allow 
for a more accurate definition of the functional potential of OECs, helping to understand 
their regenerative potential for clinical applications. 
In vivo formation of perfused microvessels by ECs appears to be dependent on their 
communication with other vascular cell types, like pericytes, SMCs and fibroblasts, as 
well as with other specialized cell types, such as osteoblasts, MSCs, and others, with a 
beneficial effect for vascular structures formation and stabilization. 
However, key issues related with vascularization remain unanswered, including: (i) 
the lack of uniform cellular definitions, since phenotypical characterization is still 
controversial; (ii) the inadequate functional characterization; (iii) origin of the true source 
of EPCs and whether there exists a relationship with the hematopoietic lineage; (iv) 
preferable cell type for a therapeutical application; (v) most efficient strategy to apply 
OECs for complex vascularized tissue construct formation; and (vi) the need to establish 
standardized protocols for OECs isolation and expansion, in order to improve the 
comparison between different studies. Furthermore, it is also of major importance to 
determine the temporal window and the sequence of events leading to the formation of 
a functional microvasculature. 
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